Internalization of oligodeoxynucleotide antisense to type-1 plasminogen activator inhibitor mRNA in endothelial cells: A three-dimensional reconstruction by confocal microscopy

Biology of the Cell

Volumn 87, Issue 1-2, 1996, Pages 37-43

  Wyroba, Elzbieta ^a   Pawlowska, Zofia ^b   Kobylanska, Anna ^c   Pluskota, Elzbieta ^b   Maszewska, Maria ^c   Stec, Wojciech J ^c   Cierniewski, Czeslaw S ^b  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Antisense oligonucleotides; Confocal microscopy; Human endothelial cell line; Spatial distribution

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; FLUORESCENT DYE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PLASMINOGEN ACTIVATOR INHIBITOR;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL;

EID: 0030469070     PISSN: 02484900     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-4900(97)89835-8     Document Type: Article

References (25)

1. 1 Akhtar S, Basu S, Wickstrom E, Juliano RL (1991) Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). Nucleic Acids Res 19, 5551-5559
2. 2 Bennett CF, Chiang MY, Chan H, Shoemaker JEE, Mirabelli CK (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 41, 1023-1033
3. 3 Bergan R, Connell Y, Fahmy B, Neckers L (1993) Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy. Nucleic Acids Res 21, 3567-3573
4. 4 Cazenave C, Stein CA, Loreau N, Thoung T, Neckers LM, Subasinghe C, Helene CS, Cohen JS, Tolume JJ (1989) Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides. Nucleic Acids Res 17, 4255-4273
5. 5 Cierniewski CS, Babinska A, Swiatkowska M, Wilczynska M, Okruszek A, Stec WJ (1995) Inhibition by modified oligodeoxynucleotides of the expression of type-1 plasminogen activator inhibitor in human endothelial cells. Eur J Biochem 227, 494-499
6. 6 Cierniewski CS, Pluskota E, Krzeslowska J, Fijalkowska I, Kobylanska A, Koziolkiewicz M, Okruszek A, Stec WJ (1995) Inhibition by modified oligodeoxynucleotides of the expression of type-1 plasminogen activator inhibitor in human endothelial cells. Thrombos Haemostas 73, 411 (abstract)
7. 7 Erickson RP, Izant JG (1992) Gene regulation: Biology of Antisense RNA and DNA. Raven Press, New York, p 384
8. 8 Gao WY, Jaroszewski JW, Cohen JS, Cheng YC (1990) Inhibition of herpes simplex virus type-2 growth by phosphorotioate oligodeoxynucleotides. J Biol Chem 265, 20172-20178
9. 9 Geselowitz D, Neckers L (1992) Analysis of oligonucleotide binding, internalization and intracellular trafficking utilizing a novel radiolabelled crosslinker. Antisense Res Dev 2, 17-25
10. 10 Ghosh M, Ghosh K, Cohen JS (1992) Translation inhibition by phosphorothioate oligodeoxynucleotides in cell-free systems. Antisense Res Dev 2, 111-118
11. 11 Goodarzi G, Watabe M, Watabe K (1991) Binding of oligonucleotides to cell membranes at acidic pH. Biochem Biophys Res Commun 181, 1343-1351
12. 12 Kitajima I, Shinohara T, Minor T, Bibbs L, Bilakovic J, Nerenberg M (1992) Human T-cell leukemia virus type-1 tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. J Biol Chem 267, 25881-25888
13. 13 Lappalainen K, Urtti A, Söderling E, Jääskeläinen I, Syrjänen K, Syrjänen S (1994) Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells. Biochem Biophys Acta 1196, 201-208
14. 14 Leonetti JP, Mechti N, Degols G, Gagnor C, Lebleu B (1991) Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci USA 88, 2702-2706
15. 15 Loke SL, Stein CA, Zhang X, Avignan M, Cohen IS, Neckers LM (1988) Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top Microbiol Immunol 141, 282-289
16. 16 Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subasinghe C, Cohen JS, Neckers LM (1989) Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 86, 3474-3478
17. 17 Loskutoff DJ, Sawdey M, Keeton M, Schneiderman J (1993) Regulation of PAI-1 gene expression in vivo. Thromb Haemostas 70, 135-137
18. 18 Marti G, Egan W, Noguchi P, Zon G, Matsukura M, Broder S (1992) Oligodeoxynucleotide phosphorothioate fluxes and localization in hematopoietic cells. Antisense Res Dev 2, 27-39
19. 19 Murray JA, (1992) Antisense RNA and DNA. Wiley-Liss, New York
20. 20 Spiller DG, Tidd DM (1995) Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O. Antisense Res Dev 5, 13-21
21. 21 Stein CA, Mori K, Loke SI, Subasinghe C, Shinozoka K, Cohen JS, Neckers, LM (1988) Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: characterization and preliminary kinetics of cellular uptake. Gene 72, 333-341
22. 22 Stein CA, Subasinghe C, Shinozuka K, Cohen JS (1988) Physicochemical properties of phosphorothioate oligonucleotides. Nucleic Acid Res 16, 3209-3221
23. 23 Watson PH, Pon RT, Shiu RP (1992) Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotides. Exp Cell Res 202, 391-397
24. 24 Yakubov LA, Deeva EA, Zarytova VF, Ivanovna EM, Ryte AS, Yurchenko LV, Vlassov VV (1989) Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 86, 6454-6458
25. 25 Yaswen P, Stampfer MR, Ghosh K, Cohen JS (1993) Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res Dev 3, 67-77